Form D · Biotechnology
BIOXYTRAN, INC
Needham, MA · CIK 0001445815
Offering snapshot reported Mar 13, 2023 · SEC filing
- Reported sold
- $130K Offering amount: $6M
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $25K Reported outside-investor minimum
- First sale
- Nov 28, 2022 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 13, 2023 | Initial | $130,000 | No comparison | 3 | SEC filing |
| Aug 16, 2022 | Initial | $600,000 | No comparison | 1 | SEC filing |
| Jan 13, 2022 | Initial | $1,467,000 | No comparison | 34 | SEC filing |
| Jul 20, 2021 | Initial | $3,266,845 | No comparison | Not reported | SEC filing |
| Nov 5, 2019 | Initial | $332,300 | No comparison | 1 | SEC filing |
| Nov 6, 2018 | Initial | $250,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity, Debt
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $1M (estimated)
- Finders' fees
- $0
- Form D file number
- 021-475596
$600,000 in cash (10%) and 10% in warrants
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| WallachBeth Capital LLC | 147853 | Vestec Securities, Inc. · CRD 41409 |
Source: Form D, filed Mar 13, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Dale H Conaway | Director |
| Henry J. Esber | Director |
| Alan Hoberman | Director |
| Soderquist Ola | Executive |
| David Platt | Director, Executive |
| Ola Soderquist | Executive |
| Anders N. Utter | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
C/O Bioxytran, Inc. 75 2 Nd Ave, Suite 605 Ste 605
Needham, MA, 02494
Needham, MA, 02494